DIOD
Rating neutralAI MemoDiodes
As of 2026-10-17/Confidence medium
Data freshness
AI Memo
As of 2026-10-17 • Model: RankAlpha Sentiment Codex
Decision Panel
Action, confidence, horizon, and decision blockers at a glance.
Action
neutral
Confidence
medium
Horizon
—
Key catalyst
November 5 results test the Q3 outlook • 2026-11-05
Base target: $91 / p=50% prob
Biggest risk
A miss against the $510 million revenue or 35.0% gross-margin Q3 midpoint would weaken the recovery thesis. ElevATE integration, ATE demand, competition and the August convertible-note financing add execution and capital-structure risks. Q2 release Acquisition release Notes pricing
Invalidation
Break below $63 or thesis failure.
What would change my mind?
Q2 revenue reached $445.5 million, up from $366.2 million a year earlier, while GAAP gross margin rose to 33.1% from 31.5%. Meeting the Q3 outlook and realizing ElevATE's forecast contribution would support operating leverage. The deterministic prior is positive, but realization remains unconfirmed [#SEC-8K-2026-08-05] [#PR-2026-08-27]. Q2 release Acquisition release
Research note
Recommendation
neutral
Confidence
medium
As of
2026-10-17
Base target
$91
p=50%
Bull target
$112
p=25%
Bear target
$63
p=25%
Key bullets
Fast scan of bull, bear, and watch items
BullKey bullets
- ElevATE contribution and integration become measurable
- Q2 revenue reached $445.5 million, up from $366.2 million a year earlier, while GAAP gross margin rose to 33.1% from 31.5%.
- Meeting the Q3 outlook and realizing ElevATE's forecast contribution would support operating leverage.
BearKey bullets
- ElevATE's forecast revenue and accretion may not materialize on schedule; integration and ATE-demand risks are explicit in the company release.
- Company acquisition release
- Q3 revenue, margin or EPS could miss management's stated outlook [#SEC-8K-2026-08-05].
WatchKey bullets
- November 5 results test the Q3 outlook
Summary
High-level snapshot
Recommendation
neutral
Model confidence
medium
Timeframe
-
Asset
Equity
Trigger
-
Base case: $91 (p=50%)
Target spread vs base: +23% / -31%
Scenario probabilities
Bull Target: $112 (p=25%)Base Target: $91 (p=50%)Bear Target: $63 (p=25%)
Commentary
Company evidence supports a positive operating trend, and the structured deterministic prior is positive, a change from the prior baseline's negative direction. Still, the November results have not printed, the analyst-target count is unavailable, and the apparent price gap lacks verified attribution. News tone is moderately constructive; social coverage, options skew, short interest and employee sentiment were not available, so the numeric zeros above denote unavailable data rather than observed neutral readings.
As of 2026-10-17 • Updated bi-weekly / post-earningsSource: Internal modelMethodology
Analyst Summary
Thesis highlights from the latest analysis
Bull Case
Q2 revenue reached $445.5 million, up from $366.2 million a year earlier, while GAAP gross margin rose to 33.1% from 31.5%. Meeting the Q3 outlook and realizing ElevATE's forecast contribution would support operating leverage. The deterministic prior is positive, but realization remains unconfirmed [#SEC-8K-2026-08-05] [#PR-2026-08-27]. Q2 release Acquisition release
Bear Case
A miss against the $510 million revenue or 35.0% gross-margin Q3 midpoint would weaken the recovery thesis. ElevATE integration, ATE demand, competition and the August convertible-note financing add execution and capital-structure risks. Q2 release Acquisition release Notes pricing
Drivers
Scannable catalysts and supporting factors
- ElevATE contribution and integration become measurable
Scenarios
Bull Target (Scenario probability)
$112 / p=25% prob
Base Target (Scenario probability)
$91 / p=50% prob
Bear Target (Scenario probability)
$63 / p=25% prob
Analysis 2026-10-17 · RankAlpha Sentiment Codex
Analysis reference price unavailable. Targets are shown without scenario returns.
Sentiment & Exposure
News Sentiment (30d)
0.25
Social Sentiment (7d)
0.00
Events
Other notable items detected
- EVENT2026-11-05November 5 results test the Q3 outlookDiodes scheduled its Q3 results and call for November 5. Its Q2 release projected approximately $510 million of Q3 revenue, 35.0% GAAP gross margin and $1.05 non-GAAP EPS, each with stated ranges. Delivery against those figures is the clearest near-term test of demand and manufacturing utilization [#8-K-2026-10-15] [#SEC-8K-2026-08-05]. Company earnings notice Q2 releaseProb 60.00% • Move 10.00% • Priced-in 50.00%
Short-term Catalysts
Next few weeks
No short-term catalysts
Long-term Catalysts
Months to a year
- ElevATE contribution and integration become measurable2027-08-27Diodes completed its $250 million ElevATE Semiconductor acquisition on August 27. Management expects approximately $50 million of revenue in the first 12 months after closing and immediate accretion, but those are forecasts, not realized benefits. Subsequent results can test the ATE product line's contribution and integration costs [#PR-2026-08-27]. Company acquisition releaseProb 55% • Move 8% • Priced-in 40%
Risks
- ElevATE's forecast revenue and accretion may not materialize on schedule; integration and ATE-demand risks are explicit in the company release. Company acquisition release
- Q3 revenue, margin or EPS could miss management's stated outlook [#SEC-8K-2026-08-05].
- The $325 million convertible-note pricing creates future repayment or conversion considerations, although the company also arranged capped calls intended to reduce potential dilution. Company notes pricing
- The packet does not establish why its October 16 price anchor is well below the price cited in October 6 broker coverage; do not attribute that gap to operating news without evidence.
Peers
| Symbol | Summary |
|---|---|
| ON | Relevant power and analog semiconductor comparison with automotive and industrial exposure; onsemi's scale and product mix differ materially from Diodes. onsemi annual report |
| KLIC | Packet-supplied semiconductor-equipment candidate useful only as an adjacent test-market reference, not a direct analog or discrete-chip valuation peer. |
| VSH | Closest product comparison among the checked companies: Vishay sells diodes, rectifiers and MOSFETs, although its passive-components business makes consolidated comparisons imperfect. Vishay investor overview |
Sources
Internal and external references used in this analysis
- Model source: RankAlpha Sentiment Codex
- Analysis date: 2026-10-17

